Glass House Brands Q2 Loss Widens, Material Weakness Persists
GLAS sits 83% above its 52-week low of $5.15.
Summary
Glass House Brands reported a Q2 net loss of $6.8 million versus a profit of $8.7 million last year, with gross margin down sharply. A material weakness in internal controls remains unresolved.
Key Events · Earnings and Guidance · GLAS
-
Q2 Net Loss of $6.8M
Net loss attributable to the Company was $6.8 million for Q2 2026, compared to net income of $8.7 million in Q2 2025. Revenue was essentially flat at $47.0 million.
-
Gross Margin Collapses to 34%
Gross profit fell to $15.8 million from $26.1 million, as cost of goods sold rose 45% to $31.2 million. Gross margin declined from 55% to 34% year-over-year.
-
Adjusted EBITDA Down 69%
Adjusted EBITDA was $5.7 million, down from $18.1 million in Q2 2025, driven by lower gross profit and higher general and administrative expenses.
-
Material Weakness Unremediated
The material weakness in internal control over financial reporting related to IT general controls at third-party service providers remains unremediated as of June 30, 2026. Remediation efforts are ongoing.
Analysis · GLAS · Life Sciences
Glass House Brands swung to a $6.8 million net loss in Q2 2026 from an $8.7 million profit a year earlier, as gross margin collapsed to 34% from 55% on higher production costs. Adjusted EBITDA fell 69% to $5.7 million. The company also disclosed that a material weakness in internal controls over financial reporting remains unremediated, adding governance risk on top of deteriorating profitability.
At the time of this filing, GLAS was trading at $9.41 on NYSE in the Life Sciences sector, with a market capitalization of approximately $728.6M. The 52-week trading range was $5.15 to $13.93. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.